NCT05746481 2026-01-22Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain MetastasesUniversity of PittsburghPhase 2 Terminated3 enrolled 12 charts
NCT04610684 2024-03-13Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain MetastasesHoosier Cancer Research NetworkPhase 2 Terminated3 enrolled 13 charts